Abstract:In order to investigate new potential therapeutically active agents, we investigated the biological properties of two small libraries of quinoxalinones and 1,4-benzoxazin-2-ones. The results obtained showed that compounds 5, 9-11 have good cytotoxic activity against HeLa cells where the lowest IC value (10.46 ± 0.82 μM/mL) was measured for compound 10. Additionally, the most active compounds (5, 9-11) showed much better selectivity for MRC-5 cells (up to 17.4) compared to cisplatin. In vitro evaluation of the … Show more
Considering the urgency of finding a cure for vicious diseases such as tumors, we have synthesized and characterized a small series of new copper(ii) complexes with biologically important ligands such as acylpyruvate.
Considering the urgency of finding a cure for vicious diseases such as tumors, we have synthesized and characterized a small series of new copper(ii) complexes with biologically important ligands such as acylpyruvate.
“…To better understand quantitatively the magnitude of the binding strength of the compounds with CT-DNA, the quenching constant (Kq) was calculated using Sterne-Volmer equation [40] by examining the dependence of F 0 /F on [Q] (Figure 7). Quenching constant for D13 and D15, presented in Table 1, indicate that both compounds have the capability to displaced EB from the EB-DNA complex by binding to DNA through intercalation [41].…”
“…It is known that α,γ-diketo acids can be used in cycle-forming reactions with N,Nand N,O-binucleophiles, such as ortho-phenylenediamine, ortho-aminophenol, or 2amino-3-hydroxypyridine, to produce 3,4-dihydroquinoxalin-2(1H)-one and 3,4-dihydro-2H-benzo[b] [1,4]oxazin-2-one. The two latter compounds are noteworthy because of their pronounced antibacterial, anti-inflammatory, and antitumor activities [27][28][29][30][31][32][33][34].…”
The COVID-19 pandemic is ongoing as of mid-2022 and requires the development of new therapeutic drugs, because the existing clinically approved drugs are limited. In this work, seven derivatives of epoxybenzooxocinopyridine were synthesized and tested for the ability to inhibit the replication of the SARS-CoV-2 virus in cell cultures. Among the described compounds, six were not able to suppress the SARS-CoV-2 virus’ replication. One compound, which is a derivative of epoxybenzooxocinopyridine with an attached side group of 3,4-dihydroquinoxalin-2-one, demonstrated antiviral activity comparable to that of one pharmaceutical drug. The described compound is a prospective lead substance, because the half-maximal effective concentration is 2.23 μg/μL, which is within a pharmacologically achievable range.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.